Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-20T11:28:20.967Z Has data issue: false hasContentIssue false

The OECD Blue Book on Recombinant DNA Safety Considerations: it's influence on ISBR and EFSA activities

Published online by Cambridge University Press:  20 July 2007

Joachim Schiemann*
Affiliation:
Federal Biological Research Centre for Agriculture and Forestry, Institute for Plant Virology, Microbiology and Biosafety, Braunschweig, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Biosafety regulatory frameworks are intended to serve as mechanisms for ensuring the safe use of biotechnology products without imposing unacceptable risk to human health or the environment, or unintended constraints to technology transfer. The OECD Blue Book on "Recombinant DNA Safety Considerations", setting out principles and concepts for handling genetically modified organisms safely outside of contained laboratory conditions, was a milestone in the history of biotechnology. The "Recombinant DNA Safety Considerations" definitively became the major resource for the formulation of national regulatory frameworks and international regulations, including the Cartagena Protocol. 


Type
Research Article
Copyright
© ISBR, EDP Sciences, 2007

References

Casper R., Landsmann J., eds. (1992) Proceedings of the 2nd International Symposium on The Biosafety Results of Field Tests of Genetically Modified Plants and Microorganisms, Biologische Bundesanstalt für Land- und Forstwirtschaft, Braunschweig. http://www.bba.bund.de/cln_044/nn_913132/DE/Home/biolsich/gentechnik/taggoslar/Goslar.html
EFSA (2004) Guidance document of the Scientific Panel on Genetically Modified Organisms for the Risk Assessment of Genetically Modified Plants and Derived Food and Feed. The EFSA Journal 99: 1–94. http://www.efsa.europa.eu/en/science/gmo/gmo_guidance/660.html